Personal CFO Solutions LLC announced in its latest 13F filing with the U.S. Securities and Exchange Commission (SEC) that it increased its holdings in US Physical Therapy, Inc. (NYSE:USPH – free report) by 8.5% during the fourth quarter. The institutional investor acquired an additional 379 shares during the period, bringing its holdings to 4,849 shares of the company. Personal CFO Solutions LLC’s holdings in US Physical Therapy were worth $452,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their holdings of the company. RK Capital Management LLC acquired a new stake in US Physical Therapy in the fourth quarter, valued at approximately $6.166 million. Envestnet Asset Management Inc. increased its holdings in US Physical Therapy by 53.2% in the third quarter. Envestnet Asset Management Inc. now owns 163,956 shares of the company, valued at $15.04 million, after purchasing an additional 56,957 shares during the period. Bahl & Gaynor Inc. increased its holdings in US Physical Therapy by 95.5% in the fourth quarter. Bahl & Gaynor Inc. now owns 100,315 shares of the company, valued at $9.343 million, after purchasing an additional 49,013 shares last quarter. Schroder Investment Management Group increased its holdings in US Physical Therapy by 11.0% in the fourth quarter. Schroder Investment Management Group Inc. now holds 427,217 shares of the company’s stock worth $39,791,000 after purchasing an additional 42,281 shares in the last quarter. Finally, Northern Trust Corporation increased its stake in US Physical Therapy by 9.5% in the third quarter. Northern Trust Corporation now holds 227,704 shares of the company’s stock worth $20,887,000 after purchasing an additional 19,661 shares in the last quarter.
Analysts Set New Price Targets
Several brokerage firms have recently expressed their opinion on USPH. Barrington Research reaffirmed an “outperform” rating and set a $122.00 price target on shares of US Physical Therapy in a research report on Thursday, May 9th. JPMorgan Chase & Co. boosted their price target on shares of US Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. Finally, StockNews.com raised shares of US Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on MarketBeat data, the stock has an average rating of a “moderate buy” and an average price target of $125.67.
Get the latest USPH stock report
Insider Trading at US Physical Therapy
In other US Physical Therapy news, CFO, Carey P. Hendrickson sold 1,800 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. The transaction now means the CFO directly owns 21,186 shares of the company’s stock, valued at $2,272,834.08. The transaction was disclosed in a document filed with the Securities and Exchange Commission, which is available at this hyperlink. In other US Physical Therapy news, EVP, Richard Binstein sold 2,000 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $106.55, for a total value of $213,100.00. Following the completion of the sale, the Executive Vice President now directly owns 15,006 shares of the company’s stock, valued at $1,598,889.30. The transaction was disclosed in a legal filing with the Securities and Exchange Commission, which can be accessed through this hyperlink. Additionally, CFO Carey P. Hendrickson sold 1,800 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total transaction value of $193,104.00. Following the transaction, the Chief Financial Officer now owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Insiders sold 14,924 shares of the company’s stock in the last quarter for $1,563,389. Company insiders own 1.70% of the company’s shares.
US Physical Therapy Stock Performance
US Physical Therapy’s shares opened trading at $96.92 on Monday. The company’s 50-day simple moving average is $103.01 and its 200-day simple moving average is $99.21. The company’s market cap is $1.46 billion, its P/E ratio is 78.80, its price-to-earnings growth ratio is 3.69 and its beta is 1.41. The company’s debt-to-equity ratio is 0.28, its current ratio is 2.16 and its quick ratio is 2.16. US Physical Therapy’s 52-week low is $78.08 and its 52-week high is $124.11.
US Physical Therapy (NYSE:USPH – Get free report ) last announced its earnings results on Tuesday, May 7th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.07). US Physical Therapy had an ROE of 8.03% and a net margin of 4.72%. The company’s revenue for the quarter was $155.7 million, compared to analyst expectations of $153.3 million. During the same period last year, the company earned $0.59 earnings per share. The company’s revenue grew 4.8% year-over-year. Equity research analysts expect US Physical Therapy to post EPS of 2.9 this year.
US Physical Therapy Dividend Announcement
The company also recently declared a quarterly dividend, which is scheduled to be paid on Friday, June 14th. Shareholders of record on Thursday, May 23rd will be paid a dividend of $0.44. The ex-dividend date for this dividend is Wednesday, May 22nd. This equates to a dividend of $1.76 on an annualized basis, or a yield of 1.82%. US Physical Therapy has a dividend payout ratio of 143.09%.
Physical Therapy in the United States
(Free report)
US Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through its Physical Therapy Practices and Occupational Injury Prevention Services divisions. The company provides pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured workers, and neurological-related injuries.
reference
Receive news and reviews from US Physical Therapy Daily –Enter your email address below to receive a concise summary of the latest news and analyst ratings on US Physical Therapy and related companies every day with MarketBeat.com’s free email newsletter.
